Literature DB >> 25861334

DiGeorge syndrome who developed lymphoproliferative mediastinal mass.

Kyu Yeun Kim1, Ji Ae Hur1, Ki Hwan Kim1, Yoon Jin Cha2, Mi Jung Lee3, Dong Soo Kim1.   

Abstract

DiGeorge syndrome is an immunodeficient disease associated with abnormal development of 3rd and 4th pharyngeal pouches. As a hemizygous deletion of chromosome 22q11.2 occurs, various clinical phenotypes are shown with a broad spectrum. Conotruncal cardiac anomalies, hypoplastic thymus, and hypocalcemia are the classic triad of DiGeorge syndrome. As this syndrome is characterized by hypoplastic or aplastic thymus, there are missing thymic shadow on their plain chest x-ray. Immunodeficient patients are traditionally known to be at an increased risk for malignancy, especially lymphoma. We experienced a 7-year-old DiGeorge syndrome patient with mediastinal mass shadow on her plain chest x-ray. She visited Severance Children's Hospital hospital with recurrent pneumonia, and throughout her repeated chest x-ray, there was a mass like shadow on anterior mediastinal area. We did full evaluation including chest computed tomography, chest ultrasonography, and chest magnetic resonance imaging. To rule out malignancy, video assisted thoracoscopic surgery was done. Final diagnosis of the mass which was thought to be malignancy, was lymphoproliferative lesion.

Entities:  

Keywords:  DiGeorge syndrome; Lymphoproliferative disorders; Mediastinal neoplasms

Year:  2015        PMID: 25861334      PMCID: PMC4388972          DOI: 10.3345/kjp.2015.58.3.108

Source DB:  PubMed          Journal:  Korean J Pediatr        ISSN: 1738-1061


  11 in total

1.  A genetic etiology for DiGeorge syndrome: consistent deletions and microdeletions of 22q11.

Authors:  D A Driscoll; M L Budarf; B S Emanuel
Journal:  Am J Hum Genet       Date:  1992-05       Impact factor: 11.025

2.  WHO classification of tumours of haematopoietic and lymphoid tissues in 2008: an overview.

Authors:  E Sabattini; F Bacci; C Sagramoso; S A Pileri
Journal:  Pathologica       Date:  2010-06

Review 3.  Immunological aspects of 22q11.2 deletion syndrome.

Authors:  A R Gennery
Journal:  Cell Mol Life Sci       Date:  2011-10-09       Impact factor: 9.261

4.  Catechol-O-methyltransferase (COMT)-mediated metabolism of catechol estrogens: comparison of wild-type and variant COMT isoforms.

Authors:  S Dawling; N Roodi; R L Mernaugh; X Wang; F F Parl
Journal:  Cancer Res       Date:  2001-09-15       Impact factor: 12.701

Review 5.  Lymphoproliferative disorders and other tumors complicating immunodeficiencies.

Authors:  A H Filipovich; A Mathur; D Kamat; J H Kersey; R S Shapiro
Journal:  Immunodeficiency       Date:  1994

Review 6.  Understanding velocardiofacial syndrome: how recent discoveries can help you improve your patient outcomes.

Authors:  Sivakumar Chinnadurai; Steven Goudy
Journal:  Curr Opin Otolaryngol Head Neck Surg       Date:  2012-12       Impact factor: 2.064

7.  Pulmonary extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue associated with granulomatous inflammation in a child with chromosome 22q11.2 deletion syndrome (DiGeorge syndrome).

Authors:  Tawatchai Pongpruttipan; James R Cook; Miguel Reyes-Mugica; Jonathan E Spahr; Steven H Swerdlow
Journal:  J Pediatr       Date:  2012-08-21       Impact factor: 4.406

Review 8.  Genomic disorders on chromosome 22.

Authors:  Shihui Yu; William D Graf; Robert J Shprintzen
Journal:  Curr Opin Pediatr       Date:  2012-12       Impact factor: 2.856

9.  Prevalence of primary immunodeficiency in Korea.

Authors:  Jung Woo Rhim; Kyung Hyo Kim; Dong Soo Kim; Bong Seong Kim; Jung Soo Kim; Chang Hwi Kim; Hwang Min Kim; Hee Ju Park; Ki Soo Pai; Byong Kwan Son; Kyung Sue Shin; Moo Young Oh; Young Jong Woo; Young Yoo; Kun Soo Lee; Kyung Yil Lee; Chong Guk Lee; Joon Sung Lee; Eun Hee Chung; Eun Hwa Choi; Youn Soo Hahn; Hyun Young Park; Joong Gon Kim
Journal:  J Korean Med Sci       Date:  2012-06-29       Impact factor: 2.153

Review 10.  Chronic immune activation and inflammation as the cause of malignancy.

Authors:  K J O'Byrne; A G Dalgleish
Journal:  Br J Cancer       Date:  2001-08-17       Impact factor: 7.640

View more
  2 in total

1.  Risk of malignancy in 22q11.2 deletion syndrome.

Authors:  Toer Stevens; Jutte van der Werff Ten Bosch; Marjan De Rademaeker; Ann Van Den Bogaert; Machiel van den Akker
Journal:  Clin Case Rep       Date:  2017-03-02

Review 2.  Primary Immunodeficiency and Cancer in Children; A Review of the Literature.

Authors:  Rejin Kebudi; Ayca Kiykim; Merve K Sahin
Journal:  Curr Pediatr Rev       Date:  2019
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.